|
MediVas, LLC, to Present Blood and Tissue Compatibility
Data on PEA copolymers at the 30th Annual Society for
Biomaterials Meeting & Exposition in Memphis
SAN DIEGO -- April 21, 2005 -- MediVas, LLC, announced today that Dr. Kristin DeFife, Director of Cell Biology, is presenting blood and tissue compatibility data on its novel amino acid-based Poly(Ester Amide) copolymers (PEA) to attendees at the 30th Annual Society for Biomaterials conference. The MediVas presentation is scheduled for the cardiovascular biomaterials II: surface interactions session from 1-3pm on Friday, April 29th. The convention is being held at the Memphis Cook Convention Center.
About MediVas: Since its founding in 1998, MediVas has had one simple goal - to change the way that pharmaceuticals are delivered. From small molecule drugs to whole proteins, MediVas has developed a novel platform technology that provides solutions to meet each challenge. MediVas polymers are the first of a new generation of absorbable and biocompatible drug and biologic delivery platforms. MediVas is utilizing its novel polymer technology in collaboration with some of the world's largest pharmaceutical and medical device companies, as well as our own internal product development efforts. Using this platform technology, MediVas is currently focusing its development efforts on various therapeutic areas.
Corporate Headquarters
6275 Nancy Ridge Drive
San Diego, CA 92121
T: (858) 622-2005
F: (858) 366-7301
© MediVas, LLC
|